
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.200 | 1.200 | 0.000 |
Shares | 98.250 | 98.250 | 0.000 |
Other | 0.560 | 0.560 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.185 | 18.816 |
Price to Book | 2.691 | 3.095 |
Price to Sales | 1.778 | 2.311 |
Price to Cash Flow | 10.579 | 12.257 |
Dividend Yield | 1.625 | 2.010 |
5 Years Earnings Growth | 11.978 | 9.783 |
Name | Net % | Category Average |
---|---|---|
Technology | 21.770 | 24.615 |
Financial Services | 20.650 | 16.881 |
Consumer Cyclical | 14.120 | 10.351 |
Healthcare | 13.400 | 12.013 |
Industrials | 9.600 | 12.115 |
Communication Services | 9.490 | 8.276 |
Basic Materials | 4.690 | 3.981 |
Consumer Defensive | 4.570 | 7.115 |
Energy | 1.020 | 3.294 |
Real Estate | 0.680 | 2.782 |
Number of long holdings: 226
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 3.62 | 517.66 | +0.17% | |
Amazon.com | US0231351067 | 3.41 | 222.03 | +2.56% | |
Fiserv | US3377381088 | 2.73 | 126.07 | +1.55% | |
Meta Platforms | US30303M1027 | 2.72 | 733.07 | +0.12% | |
Elevance Health | US0367521038 | 2.53 | 349.75 | -1.22% | |
Alphabet A | US02079K3059 | 2.41 | 250.43 | -2.39% | |
Adobe | US00724F1012 | 1.94 | 357.55 | +4.12% | |
Paycom | US70432V1026 | 1.89 | 206.86 | +2.87% | |
Visa A | US92826C8394 | 1.84 | 347.21 | +0.81% | |
TransUnion | US89400J1079 | 1.78 | 80.94 | +1.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LI Aktier Globale Indeks | 6.82B | 2.90 | 19.25 | 11.43 | ||
LI Aktier Danmark | 314.09M | -5.85 | 5.74 | 5.86 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review